NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

Active Not RecruitingNA

Sponsor: Massachusetts General Hospital

Conditions: Dysexecutive Syndrome, Post-Acute Sequelae of COVID-19

Interventions: Active tDCS, Sham tDCS

Countries: United States

The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Ability to provide informed consent
* A diagnosis of PASC as indicated by past COVID-19 infection, and persistent symptoms, including 'brain fog', confusion, short-term memory deficits, trouble concentrating, delirium, difficulties in multitasking.

Exclusion Criteria:

* History of epilepsy
* Metallic implants in the head and neck,
* Brain stimulators
* Pacemakers
* Pregnancy
* Active substance dependence (except for tobacco)
* Premorbid major neurological illness
* Severe mental illness (e.g., bipolar disorder, schizophrenia)
* Attention Deficit Hyperactivity Disorder

Locations (1)

Charlestown, Massachusetts, United States